Your browser doesn't support javascript.
loading
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aß peptide.
Gregori, Maria; Taylor, Mark; Salvati, Elisa; Re, Francesca; Mancini, Simona; Balducci, Claudia; Forloni, Gianluigi; Zambelli, Vanessa; Sesana, Silvia; Michael, Maria; Michail, Christos; Tinker-Mill, Claire; Kolosov, Oleg; Sherer, Michael; Harris, Stephen; Fullwood, Nigel J; Masserini, Massimo; Allsop, David.
Afiliação
  • Gregori M; University of Milano-Bicocca, Nanomedicine Center NANOMIB and School of Medicine and Surgery, Monza, (MB), Italy.
  • Taylor M; University of Lancaster, Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster, UK.
  • Salvati E; University of Milano-Bicocca, Nanomedicine Center NANOMIB and School of Medicine and Surgery, Monza, (MB), Italy.
  • Re F; University of Milano-Bicocca, Nanomedicine Center NANOMIB and School of Medicine and Surgery, Monza, (MB), Italy.
  • Mancini S; University of Milano-Bicocca, Nanomedicine Center NANOMIB and School of Medicine and Surgery, Monza, (MB), Italy.
  • Balducci C; Department of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico/Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Forloni G; Department of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico/Mario Negri Institute for Pharmacological Research, Milan, Italy.
  • Zambelli V; University of Milano-Bicocca, Nanomedicine Center NANOMIB and School of Medicine and Surgery, Monza, (MB), Italy.
  • Sesana S; University of Milano-Bicocca, Nanomedicine Center NANOMIB and School of Medicine and Surgery, Monza, (MB), Italy.
  • Michael M; University of Lancaster, Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster, UK.
  • Michail C; University of Lancaster, Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster, UK.
  • Tinker-Mill C; University of Lancaster, Department of Physics, Faculty of Science and Technology, Lancaster, UK.
  • Kolosov O; University of Lancaster, Department of Physics, Faculty of Science and Technology, Lancaster, UK.
  • Sherer M; University of Lancaster, Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster, UK.
  • Harris S; Quotient Bioresearch (Rushden) Ltd, Rushden, Northamptonshire, UK.
  • Fullwood NJ; University of Lancaster, Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster, UK.
  • Masserini M; University of Milano-Bicocca, Nanomedicine Center NANOMIB and School of Medicine and Surgery, Monza, (MB), Italy.
  • Allsop D; University of Lancaster, Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster, UK. Electronic address: d.allsop@lancaster.ac.uk.
Nanomedicine ; 13(2): 723-732, 2017 02.
Article em En | MEDLINE | ID: mdl-27769888

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Nanopartículas / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Nanopartículas / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália